4 Results for "

HCV genotypes 2b

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HCV genotypes 2b" in MCE Product Catalog:

20
20 Cited Publications
Cat. No.: HY-10238
CAS No.: 850876-88-9
Purity:  99.67%
Synonyms: ITMN-191; R7227; RO5190591; RG7227
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM) . Danoprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 0.05 μM .
loading...
    loading...
Cat. No.: HY-131905S
CAS No.: 1606150-08-6
BMS-986144 is an orally active inhibitor of HCV NS3/4A protease. BMS-986144 binds to the active site of HCV NS3/4A protease and induces conformational changes in the protease. BMS-986144 reduces time-dependent CYP3A4 inhibition, exhibits hepatic microsomal metabolic stability, and undergoes oxidation of the macrocyclic linker chain. BMS-986144 can be used in studies related to hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-10238R
CAS No.: 850876-88-9
Synonyms: ITMN-191 (Standard); R7227 (Standard); RO5190591 (Standard); RG7227 (Standard)
Research Areas:  

Infection

Danoprevir (Standard) is the analytical standard of Danoprevir (HY-10238). This product is intended for research and analytical applications. Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM) . Danoprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 0.05 μM .
loading...
    loading...
Cat. No.: HY-184880
CAS No.: 1410114-25-8
Target:  

HCV Protease HCV

Research Areas:  

Infection

BMS-986144 non-deuterated is the non-tritium form of BMS-986144 (HY-131905S). BMS-986144 non-deuterated is an orally active inhibitor of HCV NS3/4A protease. BMS-986144 non-deuterated binds to the active site of HCV NS3/4A protease and induces conformational changes in the protease. BMS-986144 non-deuterated reduces time-dependent CYP3A4 inhibition, exhibits hepatic microsomal metabolic stability, and undergoes oxidation of the macrocyclic linker chain. BMS-986144 non-deuterated can be used in studies related to hepatitis C virus infection .
loading...
    loading...